Mycrodose Therapeutics
Type:
Privately Held
Focus:
Development, LSD, MDMA, Psilocybin, Research
Summary:
Mycrodose Therapeutics is a US-Based pharmaceutical company specialized in the development of advanced drug delivery (ADD) systems utilizing psychedelic compounds to treat mental health and cognitive degenerative diseases. Mycrodose is one of only a few private companies that has been granted a Schedule I License to research four (4) psychedelic compounds: Psilocybin, MDMA, DMT, LSD, & Ketamine by the United States Drug Enforcement Agency (DEA).
Location:
San Diego, California, USA
Investors:
Negev Capital
The Conscious Fund
Founded:
Nov 01, 2021